Clinical Trial

Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2023 (before its estimated December 31, 2023 completion). Its status may not reflect the trial's current state.
Summary
The great harm of pancreatic diseases and the unknown etiology and pathogenesis make it difficult to intervene in most early cases in time. Previous studies by scholars and applicants at home and abroad have shown that the microflora in pancreatic tissue is closely related to chronic pancreatitis and pancreatic cancer. However, the research on the mechanism of microbial diversity in pancreatic tissue and the occurrence and development of various pancreatic diseases has not been reported. Based on the previous research, this subject continues to take various pancreatic diseases as the research object based on the database of pancreatic center and pathology department of Ruijin Hospital Affiliated to Medical College of Shanghai Jiaotong University, To explore the characteristics of microbial flora in pancreas in different pancreatic diseases and its mechanism of influence on disease microenvironment. Select specific microbial flora or targets in the pancreas for various pancreatic diseases, so as to provide new theoretical basis and practical guidance for the early diagnosis and treatment of pancreatic diseases.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05193162
Lead Sponsor Ruijin Hospital
Conditions Pancreatic Cancer, Pancreatic Disease, Microbial Colonization
Enrollment 800 participants
Start Date 2019-02-01
Primary Completion 2023-12-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2023-06-15